PBA

Paradigm Biocapital Advisors Portfolio holdings

AUM $2.34B
1-Year Est. Return 13.3%
This Quarter Est. Return
1 Year Est. Return
+13.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$852M
AUM Growth
+$142M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
31
New
Increased
Reduced
Closed

Top Buys

1
+$36.8M
2
+$31.5M
3
+$27.3M
4
BIIB icon
Biogen
BIIB
+$23.3M
5
SNDX icon
Syndax Pharmaceuticals
SNDX
+$22.1M

Top Sells

1
+$80.1M
2
+$23.2M
3
+$17.7M
4
AKRO icon
Akero Therapeutics
AKRO
+$12.5M
5
ESPR icon
Esperion Therapeutics
ESPR
+$11.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$68.5M 8.04%
852,830
+79,748
2
$66.1M 7.76%
238,772
+84,167
3
$57.5M 6.74%
1,267,970
+417,585
4
$54.3M 6.38%
477,585
+126,180
5
$52.7M 6.18%
1,054,870
-21,721
6
$51.2M 6%
1,751,167
+114,956
7
$49.7M 5.84%
1,954,512
+869,370
8
$49M 5.75%
857,925
+84,846
9
$43.1M 5.06%
352,808
-144,539
10
$42.8M 5.03%
6,442,825
+4,739,180
11
$41.4M 4.86%
148,892
+8,331
12
$36.8M 4.32%
+286,288
13
$36.5M 4.29%
1,233,280
+74,594
14
$33.9M 3.98%
89,556
-741
15
$33.1M 3.89%
604,544
-228,721
16
$27.3M 3.21%
+882,101
17
$20.9M 2.45%
+106,210
18
$20.5M 2.41%
599,599
+315,822
19
$17M 2%
2,317,634
+102,912
20
$16.3M 1.91%
890,105
+370,849
21
$15.8M 1.86%
+515,274
22
$12.9M 1.51%
2,434,816
+364,708
23
$4.52M 0.53%
75,000
-160,826
24
– –
-520,080
25
– –
-1,719,831
1
2